Stanley-Laman Group, Ltd. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$321,000
-1.2%
3,0000.0%0.06%
+7.1%
Q4 2015$325,000
+26.5%
3,0000.0%0.06%
+7.7%
Q3 2015$257,000
-15.2%
3,0000.0%0.05%
-7.1%
Q2 2015$303,000
+31.2%
3,0000.0%0.06%
+33.3%
Q1 2015$231,000
+14.4%
3,0000.0%0.04%
+20.0%
Q1 2014$202,0003,0000.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders